|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00792038 |
|
Date of registration:
|
14/11/2008 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors
|
|
Scientific title:
|
Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors |
|
Date of first enrolment:
|
January 2009 |
|
Target sample size:
|
88 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00792038 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Sanne Kjær |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Aarhus University Hospital, Risskov |
|
|
Name:
|
Tue BH Hartmann |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Aarhus University Hospital, Risskov |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Steady state medication 3 months prior to the study
Exclusion Criteria:
1. History of head trauma or other organic brain disease
2. Pregnancy.
3. Pacemaker or other ferromagnetic materials in the body.
4. Comorbid psychiatric illnesses assessed using SCAN- interview (30) other than
moderate depression (Ham-D<17) or anxiety disorders.
5. Antipsychotics
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Obsessive-Compulsive Disorder
|
|
Primary Outcome(s)
|
|
Y-Bocs
[Time Frame: Before and after treatment approx 20 weeks apart]
|
|
Secondary ID(s)
|
|
M-20080161
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|